A diagnosis of HHT still remains likely in individuals meeting at least 3 Curacao criteria and carrying a mutation in GDF2. Conversely, those with RASA1 mutations who meet fewer than 3 Curacao criteria may need to be re-evaluated for a more plausible diagnosis such as a CM–AVM. This evidence concerns the gene GDF2 and hereditary hemorrhagic telangiectasia.